Coronary heart disease expresses itself usually as angina pectoris or myocardial infarction. At least in Norway, angina pectoris is the more common form, particularly in people under the age of 65. The vast majority of patients with myocardial infarction is admitted to hospitals while the majority of patients with angina pectoris as the sole expression of coronary heart disease seeks a general practitioner if he sees a doctor at all. Therefore the incidence of angina pectoris in the population is less well known, than the incidence of myocardial infarction and consequently the exact prognosis is hard to give.
PROGNOSIS OF ANGINA PECTORIS Christian F . B orchgrevin k
From: Department VII, Ulleval sykehus Head: Professor dr. med. Einar M. Blegen C o ro n a ry h eart disease expresses itself usually as a n g in a pectoris o r m yo ca rd ia l in farctio n . A t least in N o rw a y , a n g in a p ectoris is the m ore com m on form , p a rtic u la rly in p eop le u n d er the age o f 65. T h e va st m a jo rity o f p atients w ith m y o ca rd ia l in farction is a d m itte d to hospitals w hile the m a jo rity o f p atients w ith a n g in a pectoris as the sole expression o f co ro n ary h eart disease seeks a gen eral p ra ctitio n er i f he sees a d o cto r a t all. T h e re fo re the in cid en ce o f a n g in a pectoris in the p o p u latio n is less w ell kn ow n , than the in cid en ce o f m yo ca rd ia l in farction an d co n sequen tly the e x a ct prognosis is h a rd to give.
T h e la rg e A m e rica n studies on the prognosis o f a n g in a pectoris in clu d e a h ig h p ercen tag e o f patients w ho h a v e exp erien ced one or m ore in farctions, w h o h a ve d evelop ed h eart failu re o r w ho h ave ca rd ia c en largem en t. T h e prognosis in such patients is therefore u n likely to be the sam e as in patients w ith , so far, u n co m p licate d a n g in a pectoris.
A lth o u g h sudden d eath o r a n a cu te in farction w ill a lw ays h a n g as a D a m o cles sw ord o v e r the heads o f p atients w ith a n g in a pectoris (as it a c tu a lly does o ver the heads o f all o f us) the prognosis is p ro b a b ly n ot as g ra v e as g e n e ra lly a ccep ted 30 years ago. P a u l D . W h ite states in one o f his m a n y papers th at the a vera ge su rviva l w as th o u g h t to be less than 5 years. S u c h figures w ere u su ally d erived from auto p sy d a ta. Z o ll et al.
( 19 5 1) fo u n d a m o n g 177 auto psied patients w ith a n g in a pectoris th a t 1/3 h a d died w ith in one y e a r after start o f sym ptom s, 50 p er cen t w ith in 2 years, 75 p er ce n t w ith in 5 years a n d 90 per cen t w ith in 10 years. T o m e such figures o n ly show th a t som e patients die soon after d evelop in g a n g in a pectoris a n d th a t som e patients live for a lo n g tim e. B u t as w e do not kn o w the n u m b er o f liv in g p atients w ith a n g in a , the figures tell very little a b o u t th e e x a ct prognosis.
A s the results o f the long-term studies, m a in ly from A m e rica , a p p ea red , it w as cle a rly show n th at the prognosis a lth o u gh still g ra v e, w as a t least som ew h at b rig h ter than g e n e ra lly felt. In 1943 W h ite et al. p ublished th eir exp erien ce w ith 500 patients w ith a n g in a pectoris, fo llo w ed for alm ost 20 years, an d in 1956 R ic h a r d et al. p u blished a fo llo w -u p study. T h is is a rem arkab le study as all patients w ere traced , the sam e can u n fo rtu n ate ly n ot be said a b o u t the o th er large A m e rica n studies. T h e su rviva l cu rve is show n in F ig u re 1. H a lf o f the p atients w ere d ead years a fter diagnosis w as m ade. Som e patients w ere still a liv e 30 years after diagnosis. O n ly 20 p er cent o f the patients h ad n orm al ca rd ia c status a t the tim e o f diagnosis, an d th ey show ed a b etter p ro g nosis as the g ro u p as a w h o le, a p o in t I shall return to. 76 p er cen t o f all the deaths w ere ca rd ia c.
T h e largest stu d y w as p ublished b y B lock et al. in 1952. A lm o st 7,000 patients w ere follo w ed from 5 to 23 years. T h e a vera ge d u ratio n o f a n gin a pectoris p rio r to diagnosis w as 2 1/ 2 years and 25 per cen t o f the patients h a d exp erien ced previous in farction .
F igu re 2 shows the su rviva l cu rve o f the patients togeth er w ith the corresp o n d in g cu rve o f the n orm al p o p u latio n . It w ill be seen th at there w as a distinct h ig h er m o rta lity the first y e a r after diagnosis. T h e 5 an d 10 y ea rs' su rvival w ere 58.4 an d 37.1 p er cen t respectively against 86.9 and 70.4 in the n orm al p o p u latio n . A lm o st 20 p er cen t o f the patients co u ld not be traced after 10 years.
T a b le 1 on p ag e 56 shows th at the su rviva l rate falls w ith age. H o w ev er, w h en adjusted for n o r m al d eath , the effect o f a n g in a su rviva l is the sam e in all on a ge groups. A sim ilar o bservatio n w as m ad e by W h ite el al., i.e. th a t th e excess m o rta lity o f patients w ith a n g in a pectoris m easured in num bers o f lives is in d ep en d en t o f age.
T e v a lu a tin g effects o f drugs on the long-term prognosis. T h is situation is sim ilar to the o ne w e are fa cin g after m y o ca rd ia l in farctio n , w h ich w as cle a r ly p oin ted o u t b y o u r C h a irm a n som e years ago. In 1960, Seim , from N o rw a y , stu d ied the p ro g nosis o f a n g in a p ectoris in 600 patients follo w ed for 5 to 25 years. 99 p er cen t co u ld be traced . T h e 5 an d 10 y e a rs' su rviva l w as a b o u t 70 an d 50 per cen t, resp ectively sligh tly b etter than in B lo ck 's m a te ria l. F ig u re 3 on p ag e 57 shows that fem ales h a ve a b etter prognosis than m ales. P atien ts w ith n orm al E C G h ave a m u ch b etter prognosis than p atients w ith a b n o rm al E C G , the 5 years' m o rta l ity b e in g a b o u t 22 an d 45 p er c en t respectively.
T h e p ro b lem o f rem ission has been a tta ck ed by R isem an (1966), w h o has follo w ed 122 patients w ith a n g in a pectoris w eek ly fo r 6 m onths to 161/ 2 years. M o re than h a lf the patients show ed re missions, defined as 2 m onths o r m ore w ith o u t p ain . H a lf o f these w ere free from p ain for m ore than one y ea r. In h a lf the patients the rem ission
erien ce a rem ission o r an exa cerb atio n .
L ife In su ran ce C o m p a n ie s' In stitu te for M e d ica l Statistics a t O slo C ity H osp itals has m ade a study o f 331 p atients w ith a n g in a pectoris w ith ou t in farctio n . T h e m a jority atten d ed an o u t-p atien t clin ic, an d the others h ad been a d m itte d to m ed ical departm ents. T a b le 3 show s the ra tio o f observed/expected deaths. T h is ratio falls w ith age w h ich m a y be in terp reted to m ean th at a n g in a pectoris is m ore serious in y o u n g p atients. 
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T h e re seems to be little differen ce in the ratio w h eth er the a n g in a lasted a short o r a lo n g tim e before registration (T a b le 4). T h e d u ratio n o f the observation p eriod seems also to h a ve little in fluen ce on the excess m o rta lity (T a b le 5) on p age 58. T h is is in co n trast to the result o f B lo ck et al. Patients with Myocardial Infarction experienced infarction, and this fact may explain the high mortality in first year. Table 7 shows that there was, perhaps sur prisingly, no difference in prognosis between the patients with moderate or severe angina pectoris as White el al. have also pointed out.
By carefully reading the patients' history it turned out that the majority of the patients had angina on exertion while the minority did not, although they still got a diagnosis o f angina pec toris. Table 8 shows that only angina on exertion is correlated with excess mortality while the patients with diagnosed angina pectoris without this symptom actually seemed to have a mortality lower than normal, indicating most likely that they did in fact not have coronary heart disease. 
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The serum cholesterol level is a well known predictor of myocardial infarction in normal persons, and Table g shows that this holds true also for patients with angina pectoris. M ay medical or surgical treatment influence the prognosis in patients with angina pectoris? As far as I know, there has been no dietary study on such patients. But recent experience in Norway where a strict cholesterol Iowering diet reduced the rate of re-infarction in male survivors of acute infarction, makes it likely that such diet also would be of benefit to patients with angina pectoris.
Most of the drugs used in the treatment of angina pectoris are aimed at curing or preventing the anginal attack. Even if this goal is achieved we do not know whether these drugs actually pro long the life o f the patients, as no large long-term study exists.
Several authors have reported on the long-term effect of surgical treatment. Hallen (1964) followed 90 patients employing the method of Beck, for 21/ 2 years. The annual mortality was 7 per cent which does not permit any conclusion. Brofman ( 1960) observed 110 patients for 3-5 years, of whom 75 per cent survived 5 years. He compared his results with the study of Block et al. who found a 5 year survival rate of 58.4 per cent and concluded that his patients had benefited from the operation, a conclusion hard to accept because of lack of information on the similarity of the two groups.
It is difficult for me to discuss the prognosis of angina pectoris without mentioning the possible beneficial effect of long-term anticoagulent therapy. In 1957 we randomized patients with angina pectoris without infarction with normal blood pressure and heart size, into an anticoagu lant group and a control group. After 18 months one death has occurred in the treated group against 9 in the control group, a difference statistically significant at the 1 per cent level. I m ade a follow-up study last m onth and the Figure 4 shows the result. A ll patients are traced and followed for a m inim um o f 71/ 2 years and a m axim um o f 91/ 2 years or until death. 80 per cent o f the survivors are still on anticoagulant therapy. T h e 5 year survival in the anticoagulant treated group was 93.2 per cent, w hich is definitely higher than in any report in the literature and statisti cally significantly higher than in the control group where the survival was 77 per cent. Beyond the first years the interpretation o f the curves is difficult and comparison between them is o f little meaning. Anticoagulant therapy was started in the control group 1 1/2 to 2 years after the start o f the study as w e did not feel justified in w ithholding this therapy from the patients. T h e 10 year survival rate was the same in the two groups (75 per cent) b ut now w e have no control group for comparison. I would guess that M r. Chairm an w ould disagree w ith me, but I still think that the most likely interpretation o f these results is that anticoagulant therapy is o f value in patients with angina pectoris when given w ithin a year after the first symptoms.
Conclusion
H ow is one to conclude? T h e prognosis o f angina pectoris is as unpredictable as life itself. Some patients die soon after their first attack, some go on living almost for ever. It is extrem ely difficult i f not impossible to give an exact prog nosis in the individual patient, but as a group it is probably fair to say that they have roughly a 50 per cent chance o f surviving for 10 years. I f they already have experienced a m yocardial infarction, if they have hypertension, cardiac enlargem ent or abnorm al E C G the prognosis is poorer. I f they have no com plication to their angina their chances o f surviving for 10 years are probably about 75 per cent. T h e prognosis is independent o f age, and severity and duration of the symptoms. It is better when the angina is com bined w ith anaem ia, obesitas or thyreotoxi cosis, w hile it is worse when it is com bined with valvular heart disease. O n the w hole the prog nosis o f angina pectoris is sim ilar to the prognosis o f survivors o f m yocardial infarction.
T h e m ajority o f the patients have had angina pectoris for several years before the diagnosis was made. I f we had been able to register the patients from their first symptom this m ight have influenc ed the prognosis. It is, however, difficult to say in which way.
It is not impossible that cholesterol low ering diet and/or intensive anticoagulant therapy m ay im prove the prognosis in patients w ith angina pectoris.
